You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRSP Exercise Disclosure
Kasinger James R. · SEC Form 4 · Filed Oct 15, 2026
Exercise
Reported value range
Not reported
Kasinger James R. General Counsel And Secretary
CRSP
Transaction date
Oct 13, 2026
Public filing date
Oct 15, 2026
Filing lag
Filed 2 days later
CRSP daily price context
Close on/before transaction
$50.1
Oct 13, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Shares
- Quantity / price
- 2,113 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-423057
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$51.23K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crispr Therapeutics Ag CRSP | Sale | Oct 14, 2026 | $51.23K |
| Crispr Therapeutics Ag CRSP | Exercise | Oct 13, 2026 | Not reported |
| Crispr Therapeutics Ag CRSP Current | Exercise | Oct 13, 2026 | Not reported |